MODASMART 300

What is MODASMART 300?

MODASMART 300 is a modern pharmaceutical drug from the group of nootropics and central nervous system stimulants, which is used to maintain a state of active wakefulness and improve cognitive functions. The manufacturer of the medicinal product is the Indian company Winlife Pharma, which specializes in the production of high-quality generics and holds international certificates of compliance for its manufacturing facilities. The drug belongs to the category of agents that affect the neurotransmitter systems of the brain, in particular the metabolism of dopamine and norepinephrine. In clinical practice, MODASMART 300 is used as a means to correct excessive daytime sleepiness and restore performance during exhaustion. The release form is oral tablets, which provides convenient dosing and high bioavailability of the active substance.

The pharmacological action of MODASMART 300 is based on the ability of the active compound to modulate the activity of certain areas of the hypothalamus responsible for regulating the sleep-wake cycle. Unlike classic amphetamine-type psychostimulants, the drug does not cause severe euphoria, tremor, or sharp fluctuations in blood pressure when therapeutic doses are observed. This makes its safety profile significantly more favorable for patients requiring long-term support for concentration. Winlife Pharma provides multi-stage quality control at all stages of production, which guarantees the stability of the pharmacokinetic parameters of each batch. Thanks to this, MODASMART 300 has gained recognition among doctors and patients in many countries around the world.

The drug is part of a product line that is often considered alongside famous brands such as ASSURANS, CENFORCE, and MALEGRA, although it has a fundamentally different mechanism of action and therapeutic purpose. While the mentioned products are mainly used in urological and andrological practice, MODASMART 300 is aimed at correcting neurological conditions associated with impaired vigilance. This distribution allows medical professionals to clearly differentiate indications and avoid confusion when prescribing therapy. It is important to understand that self-administration of any of these drugs without a prior examination can be dangerous to health. That is why, before starting to take MODASMART 300, a consultation with a qualified doctor is necessary, who will assess the appropriateness of such treatment.

What is MODASMART 300 prescribed for?

The main indication for prescribing MODASMART 300 is narcolepsy — a chronic neurological disease characterized by uncontrollable daytime sleep attacks. Patients with this diagnosis experience sudden loss of muscle tone, hallucinations upon falling asleep, and fragmented night sleep, which significantly reduces the quality of life. The drug helps to stabilize the wakefulness cycle, reducing the frequency and intensity of daytime sleepiness episodes. Clinical studies demonstrate that regular intake of MODASMART 300 allows patients to return to professional activities and social life. The therapeutic effect develops gradually and reaches its maximum after several weeks of systematic use.

The second important area of application is obstructive sleep apnea syndrome, in which repeated breathing arrests occur during sleep, leading to chronic brain hypoxia and severe daytime fatigue. MODASMART 300 is prescribed as an adjunctive treatment to the primary therapy, which includes the use of CPAP devices or surgical correction of the airway. The drug does not eliminate the cause of apnea, but it effectively compensates for excessive sleepiness, allowing the patient to maintain working capacity. This approach is recognized by international protocols for the treatment of sleep disorders and confirmed by numerous randomized studies. Doctors emphasize that monotherapy with MODASMART 300 without correcting the underlying disease is not sufficient.

The drug is also used for shift work sleep disorder, when professional activity involves night shifts or frequent flights across multiple time zones. In such cases, MODASMART 300 helps adapt the body's biological clock to new conditions, reducing the manifestations of desynchronosis. In addition, in certain clinical situations, the agent may be prescribed for the symptomatic treatment of severe asthenia and reduced concentration accompanying depressive disorders or chronic fatigue. However, such use requires special caution and careful monitoring of the patient's mental state. Any expansion of indications should occur exclusively by a doctor's decision after a full examination.

Composition and active components of MODASMART 300

The active ingredient of MODASMART 300 is modafinil at a dosage of 300 milligrams per tablet. Modafinil is a synthetic compound belonging to the class of atypical psychostimulants and has a unique mechanism of action that distinguishes it from traditional amphetamines. The substance selectively increases the extracellular concentration of dopamine in the prefrontal cortex of the brain by inhibiting its reuptake. At the same time, modafinil affects histamine, norepinephrine, and glutamate receptors, creating a complex effect of activating cognitive processes. Such a multi-vector impact provides a sustained improvement in vigilance without pronounced excitation of the peripheral nervous system.

Excipients in MODASMART 300 serve to stabilize the active substance and ensure the optimal rate of its release in the gastrointestinal tract. These include microcrystalline cellulose, starch, magnesium stearate, and povidone, which are standard fillers in the pharmaceutical industry. These substances do not have independent pharmacological activity, but they guarantee the uniformity of the tablet mass and a long shelf life of the drug. The manufacturer Winlife Pharma uses highly purified raw materials that meet the requirements of international pharmacopoeias. Thanks to this, a predictable modafinil bioavailability of over 80% is achieved.

The mechanism of action of MODASMART 300 is realized through the activation of specific neurons in the lateral hypothalamus that produce orexin — a neuropeptide responsible for maintaining a state of wakefulness. Increasing orexin activity leads to enhanced ascending activating influences on the cerebral cortex, which is subjectively perceived as clarity of thinking and a surge of energy. Unlike caffeine, modafinil does not block adenosine receptors, so it does not cause tremors, tachycardia, or a sharp increase in blood pressure. This allows the drug to be used in patients with cardiovascular diseases under medical supervision. The body's individual response to modafinil may vary depending on metabolic characteristics and concomitant diseases.

Dosage of MODASMART 300

The standard therapeutic dose of MODASMART 300 for adult patients is 300 milligrams once daily, preferably in the morning hours. Taking the drug in the second half of the day may cause difficulty falling asleep, so doctors recommend taking the tablet immediately after waking up. For patients with increased sensitivity to the action of modafinil, a dose reduction to 150 milligrams is possible, which is achieved by splitting the tablet in half if a score line is present. Dosage adjustment is carried out individually depending on the clinical response and tolerability of the drug. The maximum daily dose should not exceed 400 milligrams, as a further increase is not accompanied by an enhancement of the therapeutic effect, but increases the risk of adverse reactions.

The duration of the treatment course with MODASMART 300 is determined by the nature of the underlying disease and the dynamics of symptoms. In narcolepsy, the drug can be prescribed for a long period — from several months to a year or more, with periodic evaluation of therapy effectiveness every 3–6 months. To correct sleep disorders associated with shift work, the product is used situationally, only on days when it is necessary to maintain vigilance at night. For patients with obstructive sleep apnea syndrome, MODASMART 300 is prescribed as maintenance therapy in parallel with the main treatment. Abrupt discontinuation of use after long-term administration usually does not cause a pronounced withdrawal syndrome, but a gradual dose reduction over one to two weeks is recommended.

For elderly patients and individuals with impaired liver function, a reduction in the dose of MODASMART 300 may be required due to the slowing down of active substance metabolism. In renal failure, correction is usually not required, since modafinil is excreted mainly in the form of metabolites in urine, but clearance may be reduced. In any case, the decision to change the dosage is made by the doctor based on laboratory test results and clinical observation. Exceeding the recommended dose on your own is strictly prohibited, as it can lead to the development of serious neurological and cardiovascular complications. Before starting therapy, it is necessary to undergo a complete medical examination to exclude hidden contraindications.

How to take MODASMART 300 correctly?

MODASMART 300 should be taken orally with plenty of water, preferably at the same time every morning to maintain a stable concentration of the active substance in the blood. The drug can be consumed regardless of food intake, as food does not significantly affect the bioavailability of modafinil, although fatty food may slightly slow down the rate of absorption. For patients working night shifts, intake one hour before the start of the work period is recommended so that the peak concentration of the drug coincides with the time of maximum load. The tablet should not be chewed or crushed, as this may disrupt the controlled release of the active substance. It is important to adhere to the regularity of intake to avoid fluctuations in the therapeutic effect.

If a regular dose of MODASMART 300 is missed, it should be taken as soon as possible if more than six hours remain before the next dose. If the missed dose is discovered late, you should skip the missed dose and resume your regular schedule without doubling the next dose to compensate. Doubling the dose may cause an overdose with the development of anxiety, tachycardia, headache, and sleep disturbances. Patients are advised to keep a drug intake diary, especially at the beginning of therapy, to monitor regularity and track the body's individual reaction. This approach allows the doctor to adjust the treatment regimen in a timely manner depending on the dynamics of the condition.

During the course of treatment with MODASMART 300, alcohol consumption should be avoided, as ethanol can enhance central nervous system side effects and increase the burden on the liver. It is also recommended to limit the consumption of caffeinated beverages, as their combination with modafinil can lead to excessive stimulation, tremors, and heart rhythm disturbances. Patients taking the drug should exercise caution when driving vehicles at the beginning of therapy until individual tolerance is established. Although MODASMART 300 improves vigilance, dizziness or impaired coordination may occur in some individuals. If such symptoms appear, it is necessary to refrain from activities requiring increased concentration and consult a doctor.

Side effects of MODASMART 300

The most common side effects of MODASMART 300 are headaches, occurring in 10–15% of patients at the beginning of therapy and usually diminishing after a few days of regular intake. Nausea, dry mouth, reduced appetite, and feelings of anxiety may also be observed, which are transient in nature. In some patients, insomnia is noted, especially if the drug is taken in the afternoon or evening. These symptoms usually do not require discontinuation of treatment, but may require adjustment of the dose or timing of administration. The doctor should warn the patient about the possibility of such reactions to avoid unreasonable termination of therapy.

Less common side effects of MODASMART 300 include tachycardia, increased blood pressure, chest pain, and palpitations, requiring immediate consultation with a cardiologist. From the psychic sphere, irritability, emotional lability, depressed mood, or, conversely, excessive excitability may occur. In rare cases, allergic reactions in the form of skin rash, itching, hives, as well as angioedema are observed, requiring emergency medical care. A serious, although rare, complication is the development of Stevens-Johnson syndrome or toxic epidermal necrolysis, which are life-threatening to the patient. If any unusual symptoms appear, you must immediately stop taking the drug and seek medical help.

Long-term use of MODASMART 300 may be accompanied by the development of tolerance, when the initial dose ceases to provide the necessary therapeutic effect. In such cases, the doctor may recommend periodic breaks in taking the drug or a review of the treatment regimen. It is important to understand that the body's individual response to modafinil can differ significantly depending on the genetic characteristics of metabolism, age, and the presence of concomitant diseases. Patients should undergo regular follow-up examinations, including blood pressure monitoring, electrocardiography, and liver function laboratory tests. Only under systematic medical supervision can risks be minimized and the safety of long-term therapy ensured.

Contraindications of MODASMART 300

Absolute contraindications to the use of MODASMART 300 are hypersensitivity to modafinil or any auxiliary component of the drug, as well as a history of severe allergic reactions to other psychostimulants. The drug is not prescribed to patients with diagnosed hypertrophic cardiomyopathy, severe heart rhythm disorders, uncontrolled arterial hypertension, and recent myocardial infarction. Severe anxiety, psychomotor agitation, and psychotic disorders are also contraindications, as modafinil can exacerbate productive symptoms. In patients with liver cirrhosis or severe hepatic insufficiency, the drug is contraindicated due to impaired metabolism of the active substance. Children under 18 years of age are an absolute contraindication, as the safety and efficacy of modafinil in the pediatric population have not been established.

Relative contraindications requiring special caution include moderate arterial hypertension, ischemic heart disease, history of cerebrovascular accidents, and epilepsy. In such cases, MODASMART 300 can be prescribed only after a careful assessment of the benefit-risk ratio, with mandatory monitoring of the state of the cardiovascular system. In patients with mental illnesses, including depression, bipolar disorder, or schizophrenia, the drug should be used with extreme caution due to the risk of symptom exacerbation. If there is a history of substance abuse, special vigilance is required, as modafinil has a certain potential for developing dependence. The doctor must collect a full patient history before prescribing the drug.

The use of MODASMART 300 during pregnancy is not recommended, as animal studies have shown potential adverse effects on fetal development, and controlled studies involving pregnant women have not been conducted. Women of childbearing age should use reliable methods of contraception during therapy, as modafinil can reduce the effectiveness of hormonal contraceptives. During breastfeeding, the drug is contraindicated, as the active substance passes into breast milk. Elderly patients require special attention due to an increased risk of cardiovascular complications and liver function impairments. Before starting therapy, consultation with a doctor is mandatory, who will take into account all individual characteristics of the body.

Interaction of MODASMART 300 with other drugs and alcohol

MODASMART 300 can interact with a number of medicinal products, altering their effectiveness or increasing the risk of adverse reactions. Modafinil is an inducer of cytochrome P450 enzymes, particularly the CYP3A4 isoenzyme, which leads to accelerated metabolism of many drugs. Particularly important is the interaction with hormonal contraceptives, the effectiveness of which is significantly reduced; therefore, women are recommended to use additional or alternative methods of preventing pregnancy. The drug can also lower blood concentrations of cyclosporine, certain antiviral agents, and antidepressants, requiring adjustment of their dosage. Concomitant use with anticoagulants, such as warfarin, requires regular monitoring of blood clotting parameters.

Alcohol consumption during treatment with MODASMART 300 is strictly not recommended, as ethanol can enhance toxic effects on the central nervous system and liver. Combining modafinil with alcohol can lead to unpredictable reactions: from excessive sedation to paradoxical excitation and impaired motor coordination. In addition, alcohol reduces the therapeutic effectiveness of the drug, which may prompt the patient to independently increase the dose. Regarding driving vehicles, MODASMART 300 usually improves vigilance and reaction speed; however, at the beginning of therapy, dizziness or visual impairment may occur. Patients should refrain from driving until individual tolerance to the drug is established.

Where to buy MODASMART 300 in Ukraine

MODASMART 300 is available for purchase in pharmacy chains in Ukraine, as well as through specialized online platforms that deliver medicines. The drug is dispensed by prescription, so before placing an order, it is necessary to have an appropriate medical prescription. This approach ensures that the patient receives a quality certified product rather than a counterfeit that could be dangerous to health. The cost of MODASMART 300 may vary depending on the region, pharmacy chain, and delivery terms, so it is recommended to compare offers from several suppliers. The drug should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children.

When purchasing MODASMART 300, it is important to pay attention to the integrity of the packaging, the presence of protective elements, and the matching of the serial number with the data of the manufacturer Winlife Pharma. The original drug is always accompanied by instructions for use in the Ukrainian language containing full information on composition, dosage, and possible side effects. Patients are advised to buy medicines only from verified suppliers holding a license for pharmaceutical activities. The shelf life of MODASMART 300 is usually 24 months from the date of manufacture, after which the use of the drug is prohibited. Before starting administration, it is mandatory to consult a doctor, as self-treatment can be harmful to health.